ClinicalTrialsFinder
RecruitingNCT06077942

FX Shoulder Solutions Retrospective / Prospective Clinical Study

Sponsor

FX Shoulder Solutions

Enrollment

600 participants

Start Date

Dec 6, 2022

Study Type

OBSERVATIONAL

Conditions

Osteoarthritis ShoulderRotator Cuff Syndrome of Shoulder and Allied DisordersFracture, Shoulder

Summary

Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.

Eligibility

Inclusion Criteria1

  • Received an FX Shoulder Solutions replacement medical device in accordance with the Indications for Use based upon surgeons' determination and standard of care for the selected device system beginning January 1, 2018, through June 30, 2023.
Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEFX Artificial Shoulder Prosthesis

Humelock II Anatomic Shoulder System, Humelock II Reversible Shoulder System, Humelock Reverse Shoulder System, Humeris Shoulder System, Easytech Anatomical Shoulder System, PRCT II Fracture Plate, V-135

Locations(2)

OrthoArizona

Gilbert, Arizona, United States

Advanced Orthopedics Institute

The Villages, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06077942

Related Trials

Perform Humeral System Study

NCT0506754310 locations

FX Shoulder Prospective Clinical Study

NCT060788654 locations

The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis

NCT049299511 location

Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty

NCT049684053 locations

Prophylactic Conjoint Tendon Lengthening During Reverse Shoulder Arthroplasty Outcomes

NCT067299831 location